Search for Clinical Trial Results

Sponsored By

Botulism - 15 Studies Found

Status Study
Completed Study Name: Botulism Outbreak in Thailand (Episode II)
Condition: Botulism
Date: 2006-07-02
Interventions:
  • Drug: Botulinum AntiToxin
  • Procedure: neuro
Completed Study Name: Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism
Condition: Botulism
Date: 2011-09-26
Interventions: Drug: 3,4-diaminopyridine test dose 10 mg then 20 mg, then depending on tolerance and efficacy full-dose
Enrolling by invitation Study Name: BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
Condition: Botulism
Date: 2014-01-29
Interventions: Biological: One 5 mL of blood will be collected. The blood sample should be collected no later than 24 h
Completed Study Name: Treatment of Survivors After Botulism Outbreak
Condition:
  • Respiratory Failure
  • Botulism

Date: 2006-03-30
Interventions:
  • Drug: Botulinum AntiToxin
  • Procedure: neuro
Completed Study Name: Study of Human Botulism Immunoglobulin in Infants With Botulism
Condition:
  • Infant Botulism
  • Botulism
    • Date: 1999-10-18
    Interventions: Drug: botulism immune globulin
Completed Study Name: Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid
Condition: Botulism
Date: 2012-10-03
Interventions: Biological: rBV A/B rBV A/B injections will consist of a single 40 µg injection of total antigen (2
Completed Study Name: Phase 1 PK Study of XOMA 3AB
Condition: Botulism
Date: 2011-05-05
Interventions:
  • Drug: XOMA 3AB Single intraven
Enrolling by invitation Study Name: BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin
Condition: Botulism
Date: 2014-01-29
Active, not recruiting Study Name: Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632
Condition: Botulism
Date: 2016-05-12
Interventions:
  • Biological: NTM-1632 Monoclona
Suspended Study Name: Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
Condition: Botulism
Date: 2013-09-06
Interventions:
  • Biological: rBV A/B 0.5 mL dos
Next >>>